Orcet-M Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, formulated for the effective management of allergic conditions. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 histamine receptors, thereby alleviating symptoms such as sneezing, rhinorrhea, nasal congestion, and pruritus associated with allergic rhinitis and chronic urticaria. Montelukast, a leukotriene receptor antagonist, blocks the cysteinyl leukotriene receptor CysLT1, reducing inflammation, bronchoconstriction, and mucus production, which are key pathophysiological features in asthma and allergic rhinitis. The synergistic action of these two agents provides comprehensive relief from allergic symptoms and helps in preventing asthma exacerbations. Orcet-M is indicated for the treatment of allergic rhinitis, chronic idiopathic urticaria, and as adjunctive therapy in asthma management. The combination enhances patient compliance by reducing pill burden and improving symptom control. It is generally well-tolerated, with a low incidence of adverse effects such as headache, fatigue, and gastrointestinal disturbances. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision. Orcet-M Tablet offers a convenient and effective therapeutic option for patients suffering from allergic respiratory conditions.